APA (7th ed.) Citation

Demir, S., Hotes, A., Schmid, T., Cairo, S., Indersie, E., Pisano, C., . . . Kappler, R. (2024). Drug prioritization identifies panobinostat as a tailored treatment element for patients with metastatic hepatoblastoma. Journal of Experimental & Clinical Cancer Research (17569966), 43(1), 1. https://doi.org/10.1186/s13046-024-03221-6

Chicago Style (17th ed.) Citation

Demir, Salih, et al. "Drug Prioritization Identifies Panobinostat as a Tailored Treatment Element for Patients with Metastatic Hepatoblastoma." Journal of Experimental & Clinical Cancer Research (17569966) 43, no. 1 (2024): 1. https://doi.org/10.1186/s13046-024-03221-6.

MLA (9th ed.) Citation

Demir, Salih, et al. "Drug Prioritization Identifies Panobinostat as a Tailored Treatment Element for Patients with Metastatic Hepatoblastoma." Journal of Experimental & Clinical Cancer Research (17569966), vol. 43, no. 1, 2024, p. 1, https://doi.org/10.1186/s13046-024-03221-6.